You are here
Mersana Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference
CAMBRIDGE, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) targeting cancers in areas of high unmet need, today announced that Anna Protopapas, President and Chief Executive Officer, will present a company overview at the 8th Annual SVB Leerink Global Healthcare Conference in New York City, NY on Wednesday, February 27, 2019 at 11:30 a.m. ET.
Wednesday, February 20, 2019 - 08:00